التفاصيل البيبلوغرافية
| العنوان: |
Regular formoterol plus inhaled corticosteroid vs. salmeterol plus inhaled corticosteroid for asthma. |
| المؤلفون: |
Steward, Matthew1 (AUTHOR) matt.steward1@nhs.net, Sheth, Shailee2 (AUTHOR) |
| المصدر: |
Clinical & Experimental Allergy. May2023, Vol. 53 Issue 5, p491-494. 4p. 1 Graph. |
| مصطلحات موضوعية: |
*COUGH, *FORMOTEROL, *SALMETEROL, *WHEEZE, *DRUG side effects, *CORTICOSTEROIDS, *ASTHMA |
| مستخلص: |
Regular treatment with formoterol and an inhaled corticosteroid versus regular treatment with salmeterol and an inhaled corticosteroid for chronic asthma: serious adverse events. Keywords: asthma; bronchodilator agents; corticosteroids; drug side effects EN asthma bronchodilator agents corticosteroids drug side effects 491 494 4 05/10/23 20230501 NES 230501 Key messages Combined inhaled corticosteroids (ICSs) and long-acting beta-agonist therapy improve asthma outcomes compared with the long-acting beta-agonist monotherapy. Ensuring asthma treatments are safe is imperative to minimise healthcare utilisation and improve outcomes for these patient groups. [Extracted from the article] |
| قاعدة البيانات: |
Academic Search Index |
